RBC Capital raises KLA stock price target to $1,700 on results

RBC Capital raised KLA’s price target to $1,700 from $1,600 while keeping a Sector Perform rating, but the stock already trades at $1,816, above target. KLA beat Q3 2026 EPS and revenue expectations at $9.40 and $3.42 billion, and management slightly raised its 2026 wafer fabrication equipment outlook while signaling 2027 growth acceleration. The tone is constructive on fundamentals, but RBC sees limited near-term catalysts and views the shares as expensive at 39x calendar 2026 earnings.

Analysis

KLAC’s issue is not fundamentals so much as duration: the market already prices in a lot of process-control share gains, so modestly better execution is increasingly being met with diminishing multiple expansion. The key second-order effect is that when a leader in inspection/metrology is valued at a premium despite only mid-single-digit visibility into near-term acceleration, it becomes a sentiment tell for the broader semi-cap group—particularly names more levered to leading-edge node starts and cyclical DRAM spend. In that setup, KLAC can stay “good” while still underperforming on any wobble in capex rhetoric.

The more interesting read-through is to TSM and the equipment chain. If TSM is not pushing a fresh node ramp this year, process-control intensity can still rise, but the mix shifts toward sustaining capex and installed-base monetization rather than a broad step-up in new tool demand. That tends to favor service-heavy vendors and hurts the multiple on pure-play growth names that need node transitions to re-rate. It also implies that downstream suppliers with more exposure to new-node complexity may see a lagged revenue pulse versus the headline WFE environment.

The contrarian view is that the stock may not be as overextended as the headline multiple suggests if 2027 acceleration is real and the services annuity keeps compounding. But the market usually wants a near-term catalyst to pay up for “visibility later,” and absent a node-transition catalyst from TSM or a faster DRAM recovery, that catalyst is weak over the next 1-2 quarters. The setup is therefore less about shorting quality and more about fading crowded optimism in the equipment subgroup where earnings resilience is already fully reflected.

Key Decisions for Investors

• Stay neutral-to-underweight KLAC into the next 1-2 quarters; upside/risk looks asymmetric only on a pullback of 10-15% or if 2027 capex visibility becomes tangible.
• Pair trade: long KLAC / short a more node-beta equipment name over 1-3 months only if you want to express quality; otherwise avoid outright longs because the re-rating window is narrow.
• Use TSM as the macro tell: if TSM signals a new-node cadence in the next 1-2 earnings cycles, add KLAC on strength; absent that, expect multiple compression rather than expansion.
• For a tactical hedge, buy KLAC put spreads 2-3 months out against a long semi-cap basket; the risk/reward improves if the group de-rates on any capex disappointment.
• Prefer service-heavy semiconductor infrastructure exposure over pure growth capex names; the annuity stream should hold better if WFE stays strong but node starts remain muted.